Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis

PURPOSE: The objective was to evaluate the clinical results obtained from the use of immunosafe plasma rich in growth factors (isPRGF) in the treatment of patients with cicatrizing conjunctivitis (CC) who had not responded to the usual therapy. PATIENTS AND METHODS: This is a retrospective study tha...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Sen-Corcuera, Borja, Montero-Iruzubieta, Jesús, Sánchez-Ávila, Ronald M, Orive, Gorka, Anitua, Eduardo, Caro-Magdaleno, Manuel, Merayo-Lloves, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306461/
https://www.ncbi.nlm.nih.gov/pubmed/32606577
http://dx.doi.org/10.2147/OPTH.S252253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306461/
https://www.ncbi.nlm.nih.gov/pubmed/32606577
http://dx.doi.org/10.2147/OPTH.S252253

Ejemplares similares